Cargando…

Repurposing nonnucleoside antivirals against SARS-CoV2 NSP12 (RNA dependent RNA polymerase): In silico-molecular insight

The pandemic of SARS-CoV-2 has necessitated expedited research efforts towards finding potential antiviral targets and drug development measures. While new drug discovery is time consuming, drug repurposing has been a promising area for elaborate virtual screening and identification of existing FDA...

Descripción completa

Detalles Bibliográficos
Autores principales:	Begum, Feroza, Srivastava, Amit Kumar, Ray, Upasana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282484/ https://www.ncbi.nlm.nih.gov/pubmed/34303192 http://dx.doi.org/10.1016/j.bbrc.2021.07.050

Ejemplares similares

Repurposing antiviral drugs against the human monkeypox virus DNA-dependent RNA polymerase; in silico perspective
por: Abduljalil, Jameel M., et al.
Publicado: (2022)

In silico structure modelling of SARS-CoV-2 Nsp13 helicase and Nsp14 and repurposing of FDA approved antiviral drugs as dual inhibitors
por: Gurung, Arun Bahadur
Publicado: (2020)

The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2010)

The RNA polymerase activity of SARS-coronavirus nsp12 is primer dependent
por: te Velthuis, Aartjan J. W., et al.
Publicado: (2011)

Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp12/7/8 RNA-dependent RNA polymerase
por: Bertolin, Agustina P., et al.
Publicado: (2021)

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors
por: Kirchdoerfer, Robert N., et al.
Publicado: (2019)

Insight into the Tropism of Dengue Virus in Humans
por: Begum, Feroza, et al.
Publicado: (2019)

Targeting SARS-CoV-2 RNA-dependent RNA polymerase: An in silico drug repurposing for COVID-19
por: Baby, Krishnaprasad, et al.
Publicado: (2020)

Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
por: Bello-Pérez, Melissa, et al.
Publicado: (2018)

In silico studies of selected multi-drug targeting against 3CLpro and nsp12 RNA-dependent RNA-polymerase proteins of SARS-CoV-2 and SARS-CoV
por: Udofia, Inemesit A., et al.
Publicado: (2021)

Repurposing of potential antiviral drugs against RNA-dependent RNA polymerase of SARS-CoV-2 by computational approach
por: Gangadharan, Sivakumar, et al.
Publicado: (2022)

In-Silico targeting of SARS-CoV-2 NSP6 for drug and natural products repurposing
por: Abdelkader, Ahmed, et al.
Publicado: (2022)

Andrographolide binds to spike glycoprotein and RNA-dependent RNA polymerase (NSP12) of SARS-CoV-2 by in silico approach: a probable molecule in the development of anti-coronaviral drug
por: Srikanth, Lokanathan, et al.
Publicado: (2021)

Structural and Biochemical Characterization of the nsp12-nsp7-nsp8 Core Polymerase Complex from SARS-CoV-2
por: Peng, Qi, et al.
Publicado: (2020)

Biochemical characterization of a recombinant SARS coronavirus nsp12 RNA-dependent RNA polymerase capable of copying viral RNA templates
por: Ahn, Dae-Gyun, et al.
Publicado: (2012)

Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz
por: Jordaan, Maryam A, et al.
Publicado: (2017)

In silico analysis of RNA-dependent RNA polymerase of the SARS-CoV-2 and therapeutic potential of existing antiviral drugs
por: Mondal, Sunil Kanti, et al.
Publicado: (2021)

Targeting the vital non-structural proteins (NSP12, NSP7, NSP8 and NSP3) from SARS-CoV-2 and inhibition of RNA polymerase by natural bioactive compound naringenin as a promising drug candidate against COVID-19
por: Aleebrahim-Dehkordi, Elahe, et al.
Publicado: (2023)

Novel Nonnucleoside Inhibitors of Zika Virus Polymerase Identified through the Screening of an Open Library of Antikinetoplastid Compounds
por: Sáez-Álvarez, Yanira, et al.
Publicado: (2021)

Repurposing Antiviral Drugs for Orthogonal RNA‐Catalyzed Labeling of RNA
por: Ghaem Maghami, Mohammad, et al.
Publicado: (2020)

Structural Homology-Based Drug Repurposing Approach for Targeting NSP12 SARS-CoV-2
por: Aljuaid, Abdulelah, et al.
Publicado: (2022)

Hijacking the Host Immune Cells by Dengue Virus: Molecular Interplay of Receptors and Dengue Virus Envelope
por: Begum, Feroza, et al.
Publicado: (2019)

Insight into the Hantaan virus RNA-dependent RNA polymerase inhibition using in-silico approaches
por: Faisal, Shah, et al.
Publicado: (2022)

Repurposing FDA-approved phytomedicines, natural products, antivirals and cell protectives against SARS-CoV-2 (COVID-19) RNA-dependent RNA polymerase
por: Kandeel, Mahmoud, et al.
Publicado: (2020)

The SARS-CoV nsp12 Polymerase Active Site Is Tuned for Large-Genome Replication
por: Campagnola, Grace, et al.
Publicado: (2022)

In Silico Binding of 2-Aminocyclobutanones to SARS-CoV-2 Nsp13 Helicase and Demonstration of Antiviral Activity
por: Mohammad, Thahani S. Habeeb, et al.
Publicado: (2023)

In Silico Identification and In Vitro Validation of Repurposed Compounds Targeting the RSV Polymerase
por: Xu, Eric, et al.
Publicado: (2023)

Identification of daclatasvir as a repurposed drug against Nsp15 of SASR-CoV2 (COVID-19) by using in silico approaches
por: Jha, Prakash, et al.
Publicado: (2021)

The Mosquito Immune System and the Life of Dengue Virus: What We Know and Do Not Know
por: Mukherjee, Debica, et al.
Publicado: (2019)

Transient and stabilized complexes of Nsp7, Nsp8, and Nsp12 in SARS-CoV-2 replication
por: Wilamowski, Mateusz, et al.
Publicado: (2021)

SARS-CoV-2 RNA Dependent RNA polymerase (RdRp) – A drug repurposing study
por: Ahmad, Jamshaid, et al.
Publicado: (2020)

The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension
por: te Velthuis, Aartjan J.W., et al.
Publicado: (2012)

In Silico Insights towards the Identification of SARS-CoV-2 NSP13 Helicase Druggable Pockets
por: Ricci, Federico, et al.
Publicado: (2022)

SARS-CoV-2 RNA polymerase as target for antiviral therapy
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Computational drug repurposing in the age of COVID-19: mixing antiviral cocktails in silico
por: Diao, James A., et al.
Publicado: (2022)

Insighting isatin derivatives as potential antiviral agents against NSP3 of COVID-19
por: Ilyas, Mubashar, et al.
Publicado: (2022)

Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in silico perspective
por: Shahabadi, Nahid, et al.
Publicado: (2023)

Analyses of spike protein from first deposited sequences of SARS-CoV2 from West Bengal, India
por: Begum, Feroza, et al.
Publicado: (2023)

Activation of the SARS-CoV-2 NSP14 3′–5′ exoribonuclease by NSP10 and response to antiviral inhibitors
por: Riccio, Amanda A., et al.
Publicado: (2021)

Biochemical and Structural Insights into the Mechanisms of SARS Coronavirus RNA Ribose 2′-O-Methylation by nsp16/nsp10 Protein Complex
por: Chen, Yu, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_cf2d86194gfn48l9mdr5h2i3nr